Krebs Biochemicals and Industries Limited
KREBSBIO · NSE · ₹64 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Krebs Biochemicals and Industries Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 27.4%; Net loss was ₹2.48 crore.
Quarter ended 2026-06-30 · standalone · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹7 cr | +27.4% | Net profit: ₹-2 cr | — | -35.6% | Company filing source |
| Mar 2026 | Revenue: ₹7 cr | +11.6% | Net profit: ₹-2 cr | — | -34.4% | Company filing source |
| Dec 2025 | Revenue: ₹7 cr | — | Net profit: ₹-3 cr | — | -43.0% | Company filing source |
| Sep 2025 | Revenue: ₹4 cr | — | Net profit: ₹-6 cr | — | -147.4% | Company filing source |
| Jun 2025 | Revenue: ₹5 cr | -57.5% | Net profit: ₹-5 cr | — | -97.1% | Company filing source |
| Mar 2025 | Revenue: ₹6 cr | — | Net profit: ₹-8 cr | — | -135.5% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Ipca Laboratories Limited 49.6%HEMALATHA RAVI 12.5%AVINASH RAVI 9.9%SUN PHARMACEUTICAL INDUSTRIES LTD 4.8%GUTTIKONDA RAJASEKHAR 1.9%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Krebs Biochemicals and Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018…
05 Oct 2026 · document
- Shareholders meeting. Krebs Biochemicals and Industries Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September…
29 Sep 2026 · document
- Shareholders meeting. Krebs Biochemicals and Industries Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, …
29 Sep 2026 · document
- Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regul…
21 Sep 2026 · document
- Updates. Krebs Biochemicals and Industries Limited has informed the Exchange regarding 'Machine Readable financial results for the quarter ended 30.06.2026.'.…
07 Sep 2026 · document
- Krebs Biochemicals and Industries Limited has informed the Exchange about Copy of Newspaper Publication…
07 Sep 2026 · document
- Shareholders meeting. Krebs Biochemicals and Industries Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29,…
04 Sep 2026 · document
- Krebs Biochemicals and Industries Limited has informed the Exchange about Copy of Newspaper Publication w.r.t. prior intimation of 34th AGM of the Company.…
03 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time